➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Medtronic
Baxter
Johnson and Johnson

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Vinflunine


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Vinflunine?

Vinflunine is an investigational drug.

There have been 33 clinical trials for Vinflunine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2009.

The most common disease conditions in clinical trials are Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, and Carcinoma. The leading clinical trial sponsors are Bristol-Myers Squibb, Pierre Fabre Medicament, and National Cancer Institute (NCI).

Recent Clinical Trials for Vinflunine
TitleSponsorPhase
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)Apices Soluciones S.L.Phase 1/Phase 2
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)IpsenPhase 1/Phase 2
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)Tesaro, Inc.Phase 1/Phase 2

See all Vinflunine clinical trials

Clinical Trial Summary for Vinflunine

Top disease conditions for Vinflunine
Top clinical trial sponsors for Vinflunine

See all Vinflunine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Dow
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.